Avadel Pharmaceuticals Announces U.S. Commercial Launch of LUMRYZ™  ( sodium oxybate )  for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Adults Living with Narcolepsy - Avadel Pharmaceuticals  ( NASDAQ:AVDL )